New! ProFound AI for DBT v3.0
The Clear Leader in Breast AI.
FDA Cleared, CE Mark
Contact Us for Additional Information About ProFound AI 3.0
ProFound AI for 2D Mammography
World-class artificial intelligence for 2D mammography
CE Mark Approved, not available for sale in the United States
<
>
About iCAD
iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence that empower radiologists to find cancers earlier while improving reading workflow. Our Breast Health Solutions suite delivers powerful detection and workflow solutions for 2D and 3D mammography.
ProFound Recovery
Discover powerful AI solutions to overcome imaging challenges presented by the COVID-19 pandemic
From the Newsroom
June 14, 2021
iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark ApprovalJune 8, 2021
iCAD Signs Global Distribution Agreement with SectraMay 17, 2021
iCAD to Participate in Upcoming Virtual Investor ConferencesMay 17, 2021
iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25April 28, 2021
iCAD Reports Financial Results for the First Quarter Ended March 31, 2021
» View all news »
Discover the Power of ProFound AI® for Digital Breast Tomosynthesis
Digital breast tomosynthesis (DBT) is rapidly replacing 2D mammography in breast cancer screening because of the clinical value it offers in cancer detection. However, it presents significant workload challenges for radiologists, which can affect patient care. ProFound AI® is clinically proven to assist radiologists by improving cancer detection, decreasing reading times and reducing false positives and costly patient recalls.
iNFORMED - BlogInform, connect and engage. We invite you to engage with us to participate on the topic of cancer detection solutions, patient stories, clinical expertise.View BlogMedia SpotlightThe New Normal - The Imaging Landscape in Late-Stage Pandemic DaysView ArticleClinical FeatureImproving reading time of digital breast tomosynthesis with concurrent computer aided detection.View White Paper
Supporting cancer detection for 3,500+ healthcare facilities worldwide
Speak to a specialist today at 1.866.280.2239
Resources
Precise and Powerful Healthcare Solutions
© 2020, iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.